BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2107021)

  • 21. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    González-Moreno S; Brun E; Sugarbaker PH
    Ann Surg Oncol; 2005 Jan; 12(1):72-80. PubMed ID: 15827781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
    J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms.
    Yan TD; Links M; Xu ZY; Kam PC; Glenn D; Morris DL
    Br J Surg; 2006 Oct; 93(10):1270-6. PubMed ID: 16838392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.
    Witkamp AJ; de Bree E; Kaag MM; van Slooten GW; van Coevorden F; Zoetmulder FA
    Br J Surg; 2001 Mar; 88(3):458-63. PubMed ID: 11260116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.
    Sugarbaker PH; Bijelic L; Chang D; Yoo D
    J Surg Oncol; 2010 Nov; 102(6):576-81. PubMed ID: 20737420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
    Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
    Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudomyxoma peritonei: a review of 23 cases.
    Wertheim I; Fleischhacker D; McLachlin CM; Rice LW; Berkowitz RS; Goff BA
    Obstet Gynecol; 1994 Jul; 84(1):17-21. PubMed ID: 8008316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Jablonski KA
    Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peritoneal tumor pathology - case no. 1: pseudomyxoma peritonei].
    Dartigues P
    Ann Pathol; 2015 Aug; 35(4):311-20. PubMed ID: 26210688
    [No Abstract]   [Full Text] [Related]  

  • 32. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC; Shihab O; Chandrakumaran K; Mohamed F; Cecil TD; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):396-9. PubMed ID: 25216980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment.
    Sugarbaker PH; Kern K; Lack E
    Dis Colon Rectum; 1987 Oct; 30(10):772-9. PubMed ID: 2820671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R; Causeret S; Bossard N; Faheez M; Sayag-Beaujard AC; Brigand C; Gilly F; Glehen O
    Dis Colon Rectum; 2005 Jul; 48(7):1372-9. PubMed ID: 15909071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].
    Deraco M; Kusamura S; Gronchi A
    Tumori; 2003; 89(4 Suppl):54-5. PubMed ID: 12903545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pseudomyxoma peritonei: new concept and new therapeutic approach].
    Loungnarath R; Causeret S; Brigand C; Gilly FN; Glehen O
    Ann Chir; 2005 Feb; 130(2):63-9. PubMed ID: 15737316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix.
    Elias D; Glehen O; Pocard M; Quenet F; Goéré D; Arvieux C; Rat P; Gilly F;
    Ann Surg; 2010 May; 251(5):896-901. PubMed ID: 20395843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis.
    Van der Speeten K; Stuart OA; Chang D; Mahteme H; Sugarbaker PH
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):147-56. PubMed ID: 20857115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of pseudomyxoma peritonei with intraperitoneal 10 per cent dextrose, sizofiran and cisplatin.
    Ohara N; Teramoto K
    J Obstet Gynaecol; 2002 Mar; 22(2):223. PubMed ID: 12521714
    [No Abstract]   [Full Text] [Related]  

  • 40. Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the impact of malignant dedifferentiation.
    Chua TC; Al-Zahrani A; Saxena A; Liauw W; Zhao J; Morris DL
    J Am Coll Surg; 2010 Oct; 211(4):526-35. PubMed ID: 20729102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.